When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 بازدیدها
• 07/10/23
0
0
جاسازی کنید
administrator
مشترکین
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
SORT BY-
نظرات برتر
-
آخرین نظرات